Rang	Name	Position
1	Mr. Christopher Roberts	CFO & VP of Finance
2	Mr. Piergiorgio Donati	Chief Operating Officer
3	Dr. Martin Zugel M.D., Ph.D.	Interim CEO & Chairman of the Board
4	Dr. Gary Anthony Waanders Ph.D.	Senior VP of Investor Relations & Corporate Communications
5	Dr. Matthias Maurer Ph.D.	Senior VP & General Counsel
6	Dr. Oliver Sol M.D.	VP & Head of Clinical Development
7	Dr. Julien Rongere Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance
8	Mr. Mark Danton	Executive Vice President of Information Systems & Artificial Intelligence
9	Dr. Günther Staffler Ph.D.	Executive Vice President of Development
10	Dr. Francesca Capotosti	Senior Vice President of Research

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Bvf Inc	19,94%	54,71 Mio. USD
2	Wells Fargo & Co	1,01%	2,77 Mio. USD
3	Millennium Management LLC	0,78%	2,14 Mio. USD
4	Renaissance Technologies Corp	0,63%	1,72 Mio. USD
5	BlackRock Inc	0,53%	1,45 Mio. USD
6	Arrowstreet Capital Limited Partnership	0,41%	1,12 Mio. USD
7	Dimensional Fund Advisors, Inc.	0,34%	0,94 Mio. USD
8	Northern Trust Corp	0,28%	0,77 Mio. USD
9	Citadel Advisors Llc	0,21%	0,57 Mio. USD
10	Marshall Wace Asset Management Ltd	0,13%	0,36 Mio. USD
11	Dauntless Investment Group, LLC	0,11%	0,30 Mio. USD
12	Two Sigma Investments LLC	0,10%	0,28 Mio. USD
13	UBS Group AG	0,10%	0,28 Mio. USD
14	Acadian Asset Management LLC	0,10%	0,27 Mio. USD
15	Susquehanna International Group, LLP	0,09%	0,25 Mio. USD
16	Morgan Stanley - Brokerage Accounts	0,09%	0,25 Mio. USD
17	Geode Capital Management, LLC	0,06%	0,18 Mio. USD
18	Jane Street Group LLC	0,06%	0,16 Mio. USD
19	The Goldman Sachs Group Inc	0,02%	0,06 Mio. USD
20	Bank of America Corp	0,02%	0,05 Mio. USD